Navigation Links
Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
Date:9/20/2007

- Phase III data published in the American Journal of Nephrology -

DEERFIELD, Ill., Sept. 20 /PRNewswire-FirstCall/ -- Astellas Pharma US, Inc. today announced that its Phase III data on VAPRISOL was published in the September issue of the American Journal of Nephrology. In this study, VAPRISOL showed a significant increase in serum sodium concentrations in patients with hyponatremia -- a potentially life-threatening condition that occurs when the body's sodium level falls below normal.

"This study demonstrated that VAPRISOL 40 mg/day significantly increased serum [Na+] in patients with euvolemic or hypervolemic hyponatremia," said Joseph G. Verbalis, M.D., at the Georgetown University Hospital. "VAPRISOL will likely address an important clinical need for euvolemic or hypervolemic hyponatremia in hospitalized patients."

VAPRISOL is the first in a new class of arginine vasopressin (AVP) receptor antagonists. VAPRISOL blocks both V1a and V2 vasopressin receptors, resulting in increased urine output without increased sodium loss. This effect, known as "aquaresis," increases serum sodium levels and helps to restore salt and water balance in patients with hyponatremia due to increased body water (dilutional hyponatremia).

VAPRISOL is approved by the U.S. Food and Drug Administration as a treatment for euvolemic and hypervolemic hyponatremia in hospitalized patients. VAPRISOL is not indicated for the treatment of congestive heart failure. It should only be used for the treatment of hyponatremia in patients with underlying heart failure when the expected benefit of raising serum sodium outweighs the increased risk of adverse events. The approved doses for VAPRISOL include 20 mg/day and 40 mg/day. The 80 mg/day dose used in this study is not an approved dose.

In the double-blind, multicenter study, 84 patients with serum sodium levels of 115 to <130 mEq/L were randomized to receive placebo or a 20-mg intravenous bolus of conivaptan, fo
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (NASDAQ: CYBX ) today announced results for the ... 1   Operating results for the first quarter ... 2014, and other achievements, include: , Worldwide net product ... Strong international net sales of $13.2 million, an increase of ... product sales reached a new high of $58.8 million, an ...
(Date:8/20/2014)... , Aug. 20, 2014 Northstar Global ... that after months of hard work from many ... new Snorenz formulation and package design.  The new ... B-6 back into the product due to overwhelming ... lasting effects.  Snorenz Nighttime will also include these ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Missouri blocked the sale ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/21/2014)... The City of Garden Grove is ... programming for its inaugural “Re:Imagine Garden Grove – A ... from 11 a.m. to 4 p.m., 2.85-miles of Garden ... the downtown will be filled with diverse music, dance, ... Resources (CARS), for all to enjoy. , The car-free ...
(Date:8/21/2014)... (HealthDay News) -- Black mothers are less likely than ... possible reason why: Hospitals in neighborhoods with many black ... areas with more white residents, a U.S. government study ... less common in medical centers where the black population ... for Disease Control and Prevention reported Thursday. These ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Not only is ... can save them hundreds of health-care dollars a year, a ... a professor of public health sciences at Wake Forest Baptist ... overweight and obese type 2 diabetes patients. ... randomly assigned to either an intensive "lifestyle change program" focused ...
(Date:8/21/2014)... (HealthDay News) -- Being born at a low birth weight ... a new study suggests. The findings may partly explain ... a high prevalence of low birth weight, the researchers added. ... that those with a low birth weight were 13 percent ... a normal birth weight. The risk of diabetes was 40 ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
Breaking Medicine News(10 mins):Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... adults in their late 30,s received a flu shot during ... study released today says. But about 65 percent were ... percent said they were following the issue very or moderately ... adults during the 2009-2010 H1N1 influenza epidemic, this second of ...
... Doheny HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... the risk of getting ovarian cancer, but new research shows ... surviving the deadly disease. Women with invasive epithelial ovarian ... women without the genetic variations, according to an analysis of ...
... practiced as part of routine care for people with ... pressure and cholesterol levels and keep them under control, ... February issue of Diabetes Care . Researchers ... cohort study of more than 30,000 people with diabetes ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Psychedelic ... suggest two small brain imaging studies that seem to ... mushrooms -- affects the brain. One study included ... blood while magnetic resonance imaging (MRI) scanners measured changes ...
... HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... and other signs of gastroesophageal reflux don,t get additional ... And, taking these medications when there are ... a respiratory infection, reports the study. "There,s a ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Obstetricians ... partner violence, including during prenatal visits, according to ... and Gynecologists. In addition, ob-gyns should offer ... on hand to give to patients who are ...
Cached Medicine News:Health News:Young adults responded well to swine flu 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 3Health News:Lifestyle counseling reduces time to reach treatment goals for people with diabetes 2Health News:Could 'Magic' Mushrooms Ease Depression? 2Health News:Could 'Magic' Mushrooms Ease Depression? 3Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 2Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 3Health News:Ob-Gyns Should Screen for Domestic Abuse: Experts 2
... DXC-990 camera is a 3 chip 1/2 inch color ... and a high s/n ratio. It offers picture contrast ... and knee control. The user can choose automatic exposure ... The Sony DXC-990 camera is a bayonet mount and ...
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
... image management. Mediscan is an advanced ... derived from extensive experience with clinicians. ... organize, and distribute high quality images, ... effort. Can be connected to flexible ...
For continuous intracranial monitoring of pressure, oxygen and temperature of the brain...
Medicine Products: